Table 1.

TNBC model cell lines used in this study.

Cell line	Mutations	Subgroup
HCC1806	TCF12-A482V	Basal A
MDA-MB-157	FAT4-L4468P; MSH6-R644S	Basal B
MDA-MB-231	BRAF-G4646V; CD79A-C106Y; KRAS-G13D; NF2-E231*; PBRM1-I228V; PDGFRA-Y172F; TP53-R280K	Basal B
MDA-MB-468	CACNA1D-E953D; TP53-R273H, PTEN V85_splice	Basal A

TNBC, triple-negative breast cancer.